PMID- 9094469
OWN - NLM
STAT- MEDLINE
DCOM- 19970619
LR  - 20180216
IS  - 1018-8665 (Print)
IS  - 1018-8665 (Linking)
VI  - 194
IP  - 2
DP  - 1997
TI  - Paraneoplastic subacute cutaneous lupus erythematosus: report of a case 
      associated with cancer of the lung.
PG  - 172-4
AB  - A case of subacute cutaneous lupus erythematosus (SCLE) associated with lung 
      carcinoma is presented. A review of the literature revealed only 5 other cases of 
      SCLE associated with internal malignancy. The tumor in the described case most 
      probably developed before the appearance of the eruption. Cancer chemotherapy was 
      followed by shrinkage of tumor mass and regression of the skin lesions. The 
      sequence of these events corresponds to the definition of paraneoplastic 
      dermatoses.
FAU - Brenner, S
AU  - Brenner S
AD  - Department of Dermatology, Sackler Faculty of Medicine, Tel Aviv University, 
      Israel.
FAU - Golan, H
AU  - Golan H
FAU - Gat, A
AU  - Gat A
FAU - Bialy-Golan, A
AU  - Bialy-Golan A
LA  - eng
PT  - Case Reports
PT  - Journal Article
PT  - Review
PL  - Switzerland
TA  - Dermatology
JT  - Dermatology (Basel, Switzerland)
JID - 9203244
RN  - 0 (Antibiotics, Antineoplastic)
RN  - 0 (Antineoplastic Agents)
RN  - 0 (Antineoplastic Agents, Alkylating)
RN  - 0 (Antineoplastic Agents, Phytogenic)
RN  - 0 (Dermatologic Agents)
RN  - 4QWG6N8QKH (Hydroxychloroquine)
RN  - 6PLQ3CP4P3 (Etoposide)
RN  - 80168379AG (Doxorubicin)
RN  - 8N3DW7272P (Cyclophosphamide)
RN  - Q20Q21Q62J (Cisplatin)
SB  - IM
MH  - Antibiotics, Antineoplastic/administration & dosage
MH  - Antineoplastic Agents/administration & dosage
MH  - Antineoplastic Agents, Alkylating/administration & dosage
MH  - Antineoplastic Agents, Phytogenic/administration & dosage
MH  - Antineoplastic Combined Chemotherapy Protocols/therapeutic use
MH  - Carcinoma, Small Cell/*complications/drug therapy/pathology
MH  - Cisplatin/administration & dosage
MH  - Cyclophosphamide/administration & dosage
MH  - Dermatologic Agents/therapeutic use
MH  - Doxorubicin/administration & dosage
MH  - Etoposide/administration & dosage
MH  - Female
MH  - Humans
MH  - Hydroxychloroquine/therapeutic use
MH  - Lung Neoplasms/*complications/drug therapy/pathology
MH  - Lupus Erythematosus, Cutaneous/drug therapy/*etiology/pathology
MH  - Middle Aged
MH  - Paraneoplastic Syndromes/drug therapy/*etiology/pathology
RF  - 12
EDAT- 1997/01/01 00:00
MHDA- 1997/01/01 00:01
CRDT- 1997/01/01 00:00
PHST- 1997/01/01 00:00 [pubmed]
PHST- 1997/01/01 00:01 [medline]
PHST- 1997/01/01 00:00 [entrez]
AID - 10.1159/000246090 [doi]
PST - ppublish
SO  - Dermatology. 1997;194(2):172-4. doi: 10.1159/000246090.